CAMP4 Therapeutics Corporation
CAMP
Rank in Stocks
#14899
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015... CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Share Price
$4.69
Last synced: 2026-11-09
Market Cap
$294.31M
Change (1 day)
15.52%
Change (1 year)
13.56%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade CAMP4 Therapeutics Corporation (CAMP)
Category
Healthcare
EPS for CAMP4 Therapeutics Corporation (CAMP)
EPS as of September 2026 TTM: $-2.05
According to CAMP4 Therapeutics Corporation's latest financial reports, its current EPS (TTM) is $-2.05. At the end of 2025 the company had an EPS of $-2.65, an increase over its 2024 EPS of $-2.66.
EPS history for CAMP4 Therapeutics Corporation from 2001 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-2.05 | -22.64% |
| 2025 | $-2.65 | -0.38% |
| 2024 | $-2.66 | -34.64% |
| 2023 | $-4.07 | 362.50% |
| 2022 | $-0.88 | 41.94% |
| 2021 | $-0.62 | -73.62% |
| 2020 | $-2.35 | -543.40% |
| 2019 | $0.53 | 12.77% |
| 2018 | $0.47 | -335.00% |
| 2017 | $-0.20 | -143.48% |
| 2016 | $0.46 | 0.00% |
| 2015 | $0.46 | 35.29% |
| 2014 | $0.34 | -77.92% |
| 2013 | $1.54 | 710.53% |
| 2012 | $0.19 | -258.33% |
| 2011 | $-0.12 | -72.09% |
| 2010 | $-0.43 | -78.61% |
| 2009 | $-2.01 | -42.90% |
| 2008 | $-3.52 | 162.69% |
| 2007 | $-1.34 | -309.38% |
| 2006 | $0.64 | 68.42% |
| 2005 | $0.38 | -2.56% |
| 2004 | $0.39 | 11.43% |
| 2003 | $0.35 | 6.06% |
| 2002 | $0.33 | -15.38% |
| 2001 | $0.39 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -863.90% |
US
|
|
| $-7.07 | 244.88% |
US
|
|
| $-5.29 | 158.05% |
AU
|
|
| $12.88 | -728.30% |
BE
|
|
| $21.56 | -1,151.71% |
NL
|
Questions about CAMP4 Therapeutics Corporation's earnings per share (EPS)
What is CAMP4 Therapeutics Corporation's earnings per share (EPS)?
CAMP4 Therapeutics Corporation's earnings per share (EPS) over the last twelve months is $-2.05, as of Sep 2026.
What was CAMP4 Therapeutics Corporation's earnings per share (EPS) in 2025?
In 2025, CAMP4 Therapeutics Corporation's earnings per share (EPS) was $-2.65, compared with $-2.66 in 2024.
How has CAMP4 Therapeutics Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, CAMP4 Therapeutics Corporation's earnings per share (EPS) was highest in 2021 ($-0.62) and lowest in 2023 ($-4.07).
How does CAMP4 Therapeutics Corporation's earnings per share (EPS) compare with similar companies?
CAMP4 Therapeutics Corporation's earnings per share (EPS) ($-2.05) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.